sifalimumab
sifalimumab noun: a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
Noun
sifalimumab (uncountable)
- A human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
Origin of sifalimumab
From -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).
Questions about sifalimumab
- What does sifalimumab mean?
- Sifalimumab means a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis.
- What part of speech is sifalimumab?
- Sifalimumab is a noun.
Words near sifalimumab in the dictionary
Source and license
Adapted from Wiktionary: sifalimumab (page history and authors). Text available under the Creative Commons Attribution-ShareAlike 4.0 license. Word.ws reformatted the entry and added links. Wiktionary data of 2026-09-02.
Last updated:
Cite this entry: “sifalimumab.” Word.ws, https://word.ws/sifalimumab. Based on Wiktionary, CC BY-SA 4.0.
